Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03239626

Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer

Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer: a Prospective Exploratory Trial (POHIM_RT Trial)

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Samsung Medical Center · Academic / Other
Sex
Female
Age
20 Years – 70 Years
Healthy volunteers
Accepted

Summary

To investigate the acute toxicities, late toxicities, and treatment results when the early cervical cancer patients are treated by hypofractionated intensity-modulated radiotherapy (2.5 Gy X 16 fractions, once a day) after radical hysterectomy.

Conditions

Interventions

TypeNameDescription
RADIATIONPOHIM-RTpostoperative adjuvant IMRT with hypofractionation (2.5 Gy/fraction, 16 fractions, once a day)

Timeline

Start date
2017-08-31
Primary completion
2025-04-28
Completion
2025-04-28
First posted
2017-08-04
Last updated
2025-01-03

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03239626. Inclusion in this directory is not an endorsement.

Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer (NCT03239626) · Clinical Trials Directory